Skip to main content
. 2013 Mar 7;13:45. doi: 10.1186/1471-230X-13-45

Table 5.

Between and within group comparisons at weeks 8 and 12

WEEK 8
Study parameter
A = Active product
C = Control product
A vs C
  n Mean (week 12–baseline) (SD) p value* (change from baseline) n Mean (week 12–baseline) (SD) p value* (change from baseline) p value**
IBS-SSS
50
−58.30 (84.96)
<0.001
40
−58.33 (73.37)
<0.001
0.589
Birmingham IBS symptom scale
Constipation
52
13.78 (24.47)
<0.001
41
17.24 (22.61)
<0.001
0.302
Diarrhoea
4.25 (13.78)
0.210
2.15 (7.71)
0.064
0.907
Pain
11.28 (18.88)
<0.001
13.66 (16.80)
<0.001
0.257
Total score
8.71 (13.09)
<0.001
9.44 (9.75)
<0.001
0.265
IBS specific symptoms
Pain
53
−0.58 (1.24)
0.012
41
−0.66 (1.43)
0.002
0.292
Bloating
52
−0.80 (1.44)
0.005
−0.85 (1.26)
<0.001
0.408
Flatulence
53
−0.54 (1.28)
0.002
40
−0.50 (1.08)
0.004
0.864
Composite score
52
−1.95 (3.43)
0.003
−1.96 (3.17)
<0.001
0.374
Stool frequency
346
0.07 (0.95)
0.303
276
0.10 (0.05)
0.141
0.828
Stool consistency
290
0.18 (1.17)
0.042
218
0.50 (1.23)
0.001
0.098
Bowel movement difficulty
291
−0.43 (1.01)
<0.001
224
−0.40 (0.78)
<0.001
0.623
IBS Quality of life
Dysphoria
53
14.66 (19.87)
<0.001
41
9.29 (13.95)
<0.001
0.508
Activity interference
8.20 (14.74)
0.001
6.05 (12.99)
0.001
0.924
Body image
11.95 (15.98)
<0.001
8.54 (13.46)
<0.001
0.735
Health worry
13.29 (17.81)
<0.001
7.62 (15.19)
0.002
0.428
Food avoidance
10.06 (17.63)
<0.001
5.49 (17.84)
0.039
0.372
Social reaction
10.85 (16.18)
<0.001
6.71 (12.21)
<0.001
0.462
Sexual
8.41 (18.31)
0.006
7.05 (16.92)
0.005
0.554
Relationship
7.23 (18.64)
0.015
7.01 (9.88)
<0.001
0.635
Total score
10.95 (13.14)
<0.001
7.52 (10.22)
<0.001
0.483
WEEK 12
IBS-SSS
43
−61.02 (75.78)
<0.001
33
−97.24 (90.17)
<0.001
0.028
Birmingham IBS symptom scale
Constipation
48
6.65 (22.56)
0.039
35
17.52 (23.60)
<0.001
0.011
Diarrhoea
 
3.27 (11.17)
0.048
 
2.43 (10.60)
0.133
0.889
Pain
 
10.28 (14.09)
<0.001
 
15.24 (17.38)
<0.001
<0.107
Total score
 
6.07 (9.62)
<0.001
 
10.10 (10.78)
<0.001
<0.022
IBS specific symptoms
Pain
48
−0.59 (1.24)
0.002
34
−1.04 (1.33)
<0.001
0.016
Bloating
48
−0.58 (1.39)
0.005
−1.35 (1.21)
<0.001
0.006
Flatulence
48
−0.64 (1.04)
0.001
−0.76 (1.23)
<0.001
0.383
Composite score
48
−1.81 (3.03)
<0.001
−3.16 (3.05)
<0.001
0.011
Stool frequency
311
−0.07 (0.75)
0.186
224
0.07 (0.82)
0.464
0.211
Stool consistency
247
0.26 (1.22)
0.045
181
0.31 (0.99)
0.012
0.784
Bowel movement difficulty
246
−0.35 (0.99)
<0.001
180
−0.36 (0.86)
<0.001
0.329
IBS Quality of life
Dysphoria
48
13.61 (20.12)
<0.001
34
10.83 (10.68)
<0.001
0.933
Activity interference
8.47 (12.31)
<0.001
34
7.09 (8.73)
<0.001
0.806
Body image
11.33 (14.16)
<0.001
34
8.27 (14.08)
0.005
0.857
Health worry
14.15 (21.01)
<0.001
34
9.07 (13.19)
<0.001
0.634
Food avoidance
8.16 (20.45)
0.008
34
8.58 (13.37)
<0.001
0.687
Social reaction
9.64 (17.15)
<0.001
34
9.38 (8.74)
<0.001
0.660
Sexual
8.07 (21.34)
0.031
32
10.55 (16.53)
<0.001
0.382
Relationship
7.03 (15.81)
0.002
34
5.51 (9.22)
<0.001
0.751
Total score   10.43 (12.92) <0.001 34 8.83 (6.12) <0.001 0.810

*ANCOVA with centre as a random effect, baseline as a covariate and product as a fixed effect.

**Ordinal logistic regression with centre and product fixed effects.

Stool frequency, consistency and bowel movement difficulty were recorded daily and therefore n represents the number of data items (days) included in analysis for these items.